Consensus Business Group
VC Fund
London, United Kingdom
Consensus Business Group is a VC fund in London focused on Health Care and Medical Device. Acting as advisor to companies within the Tchenguiz Family Trust, Consensus Business Group has amassed a portfolio of over 300,000 residential freeholds worth over £4 billion and a commercial portfolio worth over £2 billion.Consensus Business Group has vast experience and a proven track record of acquiring stock directly from nationalhousebuilders and developers over 20 years.As a result of their strategic investment, Consensus Business Group is believed to be the largest owner and asset manager of residential freehold interests in the UK, representing in excess of 1% of the housing stock in England and 1.2% in Greater London.Their decisions are not subject to procrastinated board approval or credit committees and as a result they are able to perform quickly and consistently. They are not dependent on debt finance and they have immediate cash availability.Consensus Business Group prides itself on having the market knowledge and expertise to stand out from its competitors, and it is their diligent and efficient acquisition practices that ensure swift transactions.
- Total investments:
- 24
- Last investment:
- Lead investor:
- 8%
Last updated:
For AI agents: llms.txt
Industries Consensus Business Group invests in
Stages Consensus Business Group invests in
Countries Consensus Business Group invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.3M–$4.5M
- Series B
- $11M–$80M
Investment Focus
Industry
- Health Care 9 (38%)
- Medical Device 6 (25%)
- Medical 5 (21%)
- Biotechnology 5 (21%)
- Food and Beverage 3 (13%)
Stage
- Series B 5 (21%)
- Funding Round 5 (21%)
- Seed 4 (17%)
- Series A 4 (17%)
- Venture - Series Unknown 2 (8%)
Country
- Israel 12 (50%)
- United States 7 (29%)
- United Kingdom 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Pearl McCourt
Founder & CEO
|
Founder & CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation, home-use, airway clearance system designed to help patients with chronic lung disease such as COPD and CF maintain clear lungs with a short, daily, proficient treatment. | $5M / Venture - Series Unknown / Feb 18, 2026 | ||
| IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost. | $3.9M / Series A / Nov 11, 2025 | ||
| IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost. | $6.1M / Series A / Feb 13, 2025 | ||
| Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013. | Series A / Jan 06, 2025 | ||
|
Celleste Bio
|
Celleste is a business that specializes in employing cell culture techniques to produce high-value cocoa ingredients, removing the need for cocoa trees to be grown. | $4.5M / Seed / Dec 05, 2024 | |
| BioProtect Ltd. is an international medical device startup. It is primarily engaged in to the business of developing and commercializing biodegradable balloon spacers for the protection of normal tissue during cancer radiation therapy. The company's current focus in the growing radiotherapy spacers market, where its ProSpace balloon spacer (CEmarked) has shown superior efficacy and safety in protecting the rectum during radiation therapy for prostate cancer. The company's technology platform of biodegradable implantable balloons suits a wide range of applications for unmet clinical needs. BioProtect was founded in the year 2004 and headquartered in Israel, with subsidiaries in Germany and US. | $28M / Sep 27, 2023 | ||
| RepAir develops a Direct Air Capture system based on a proprietary electrochemical cell technology that can capture CO2 from the air in gigaton scale. Powered solely by renewable energy, our system can be deployed at the site of carbon storage or utilizations, saving arable land and avoiding CO2 transport. | $10M / Series A / Dec 05, 2022 | ||
| WINT - Water Intelligence developing advanced solutions for smart water management and control. The company detects and stops leaks at the source using Artificial Intelligence. It is used in commercial and industrial facilities, offices, homes, and apartments. It also prevents water damage caused by leaks, broken pipes or malfunctioning watersystems.WINT customers gain deep insights about their water use to identify water waste and reduce consumption by 25%. They manage water and detect leaks using artificial intelligence and pattern matching technologies, combining high accuracy metering with advanced data analytics. WINT solutions protect global real estate portfolios and homes by revealing leaks and identifying water savings opportunities.WINT was founded in 2011 and is headquartered in New York, USA. | $15M / Series B / Jan 11, 2022 | ||
| Exero Medical is a medical device manufacturing company. It develops a biodegradable wireless sensor for early detection of anastomotic leaks following GI Surgery. Its system is designed to prevent complications by warning physicians of a potential leak, enabling early intervention.The company was founded in 2018 and is headquartered in OrYehuda, Israel. | $1.3M / Seed / Dec 15, 2021 | ||
| FlexDex is a minimally invasive surgery medical device technology that provides high dexterity. Its platform technology translates the surgeon’s hand, wrist, and arm movements from outside the patient into corresponding movements of an end-effector inside the patient’s body.The company was founded in 2010 and is headquartered in Brighton,Michigan. | $13M / Venture - Series Unknown / Aug 24, 2021 | ||
| See all 24 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Consensus Business Group invest in?
Consensus Business Group invests primarily in Health Care, Medical Device and Medical startups, most often at Series B and Funding Round stage. Most of the 24 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Consensus Business Group's check size?
Consensus Business Group typically joins rounds of $1.3M–$4.5M at Seed and $11M–$80M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Consensus Business Group participates in.
How do I contact Consensus Business Group?
Public channels for Consensus Business Group include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Consensus Business Group?
The team at Consensus Business Group includes Pearl McCourt (Founder & CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
